Carmel Egan, Ph.D., a top project management and product development executive at Eli Lilly and Co., joined the Indiana University School of Medicine as project leader of IU's Precision Health Initiative.

Dr. Egan, most recently vice president, Medicines Development Unit at Lilly, has held a series of leadership positions at Lilly. Prior to her most recent position at Lilly, she served as vice president of special Alzheimer's disease initiatives in Lilly's Biomedicines Business Unit and previously as vice president of LRL Portfolio and Project Management.

She will coordinate activities of the Precision Health Initiative as part of her role as associate dean for research affairs at the school. Dr. Egan also has been named chief operating officer of the Indiana Clinical and Translational Sciences Institute.